spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply Nordics 2018

Arena Clinical Trial Supply Nordics 2018

19-20 June 2018
Copenhagen, Denmark

Building on last year’s success, our CTS team have conducted extensive research to ensure the 2018 event programme covers all the essentials in clinical supply. In the current climate, every pharma and biotech company are trying to reduce unwanted costs, and enhance operational efficiency. To avoid costly setbacks, an innovative and effective strategy needs to be implemented!

Tailored to the Nordics region, the 5th annual conference will include highly relevant case studies, interactive roundtables and panel discussions, to assist you in your next strategic move. Find out what we have in store for you below:  

2018 Agenda Highlights

  • Collaborating with CMOs to Ensure your Drug Reaches its Destination with No Excursions
  • Streamlining your Process Development in Early Phase Trials to Optimize Supplies Quality
  • Exploring Global Regulations to Fulfil any Potential Different Requirement in All Foreign Sites
  • Pinpointing the Pros and Cons of Just In Time Planning for International Supply 

2018 Key Speakers:

  • Francisco Rizzuto, Cargo Specialist Manager for Europe, IATA
  • Jonas Fransson, Director Drug Product Development, SOBI
  • Matti Lahde, Vice President, Production, FIT Biotech
  • Kjell-Are Furnes, CEO, Ably Medical

For more information on this year’s conference, please visit: http://www.arena-international.com/ctsnoridcsor email us at: events@arena-international.com

phone +44 (0)207 936 6400
email events@arena-international.com
web www.arena-international.com/ctsnoridcs
email Copenhagen, Denmark
 
Print this page
Send to a friend
   
spacer
Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>


News and Press Releases

ChemAxon and AWS simplify getting scientists moving on the cloud

Listen to a talk by Paul Underwood of AWS introducing Biotech Blueprint, a cloud based solution for cheminformatics. The technology for novel compound registration is provided by ChemAxon.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement